Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).
Neesha C DhaniHal W HirteLisa WangJulia V BurnierAngela JainMarcus O ButlerStephen WelchGini F FlemingJean HurteauKoji MatsuoDaniela MateiWaldo JimenezCarolyn JohnstonMihaela CristeaKatia TonkinPrafull GhatageStephanie LheureuxAnjali MehtaJudy QuintosQian TanSuzanne Kamel-ReidOlga LudkovskiMing Sound TsaoJohn J WrightAmit M OzaPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Cabozantinib has activity in serous and endometrioid histology endometrial cancer. These results support further evaluation in genomically characterized patient cohorts.